Endothelial TGF-β Signaling Regulates Endothelial-Mesenchymal Transition During Arteriovenous Fistula Remodeling in Mice With Chronic Kidney Disease
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024
DOI: 10.1161/atvbaha.124.320933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Weichang Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Aca…. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Signal Transduction, Mice, Inbred C57BL, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Arteriovenous fistulae (AVF) are the preferred vascular access for hemodialysis in patients with end-stage kidney disease. Chronic kidney disease (CKD) is associated with endothelial injury, impaired AVF maturation, and reduced patency, as well as utilization. Because CKD is characterized by multiple pathophysiological processes that induce endothelial-to-mesenchymal transition (EndMT), we hypothesized that CKD promotes EndMT during venous remodeling and that disruption of endothelial TGF (transforming growth factor)-β signaling inhibits EndMT to prevent AVF failure even in the end-stage kidney disease environment. METHODS: The mouse 5/6 nephrectomy and aortocaval fistula models were used. CKD was created via 5/6 nephrectomy, with controls of no (0/6) or partial (3/6) nephrectomy in C57BL/6J mice. AVF were created in mice with knockdown of TGF-βR1/R2 (TGF-β receptors type 1/2) in either smooth muscle cells or endothelial cells. AVF diameters and patency were measured and confirmed by serial ultrasound examination. AVF, both murine and human, were examined using Western blot, histology, and immunofluorescence. Human and mouse endothelial cells were used for in vitro experiments. RESULTS: CKD accelerates TGF-β activation and promotes EndMT that is associated with increased AVF wall thickness and reduced patency in mice. Inhibition of TGF-β signaling in both endothelial cells and smooth muscle cells decreased smooth muscle cell proliferation in the AVF wall, attenuated EndMT, and was associated with reduced wall thickness, increased outward remodeling, and improved AVF patency. Human AVF also showed increased TGF-β signaling and EndMT. CONCLUSIONS: CKD promotes EndMT and reduces AVF patency. Inhibition of TGF-β signaling, especially disruption of endothelial cell–specific TGF-β signaling, attenuates EndMT and improves AVF patency in mouse AVF. Inhibition of EndMT may be a therapeutic approach of translational significance to improve AVF patency in human patients with CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, Chi…
- Department of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China (W.Z., X. Li, C.S.).
- Vascular Biology and Therapeutics Program (W.Z., L.G., H.B., Z.L., R.T., J.L., Y.O., C.T., A.Y., B.Y., K.A.M., J.G., G.T., A.D.), Yale School of Medicine, New Haven, CT.
- Division of Vascular Surgery, The University of Tokyo, Japan (R.T., Y.O.).
- Department of Medicine (Cardiovascular Medicine), Yale Cardiovascular Research Center (K.A.M.), Yale School of Medicine, New Haven, CT.
- Department of Pediatrics (J.G.), Yale School of Medicine, New Haven, CT.
ORCID-Profile: Luis Gonzalez, John Langford, Carly Thaxton, Kathleen A Martin, Julie Goodwin, George Tellides, Alan Dardik
Förderung
- NCATS NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Zhang, W., Gonzalez, L., Li, X., Bai, H., Li, Z., Taniguchi, R., Langford, J., Ohashi, Y., Thaxton, C., Aoyagi, Y., Yatsula, B., Martin, K. A., Goodwin, J., Tellides, G., Long, X., Shu, C., & Dardik, A. (2024). Endothelial TGF-β Signaling Regulates Endothelial-Mesenchymal Transition During Arteriovenous Fistula Remodeling in Mice With Chronic Kidney Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.320933
Vancouver
Zhang W, Gonzalez L, Li X, Bai H, Li Z, Taniguchi R, et al. Endothelial TGF-β Signaling Regulates Endothelial-Mesenchymal Transition During Arteriovenous Fistula Remodeling in Mice With Chronic Kidney Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.124.320933
BibTeX
@article{Zhang2024,
author = {Zhang, Weichang and Gonzalez, Luis and Li, Xin and Bai, Hualong and Li, Zhuo and Taniguchi, Ryosuke and Langford, John and Ohashi, Yuichi and Thaxton, Carly and Aoyagi, Yukihiko and Yatsula, Bogdan and Martin, Kathleen A and Goodwin, Julie and Tellides, George and Long, Xiaochun and Shu, Chang and Dardik, Alan},
title = {Endothelial TGF-β Signaling Regulates Endothelial-Mesenchymal Transition During Arteriovenous Fistula Remodeling in Mice With Chronic Kidney Disease},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
doi = {10.1161/atvbaha.124.320933}
}
EUVIMED